Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Nissei Plastic Industrial Co., Ltd. has 3 pending office actions focused within the Chemistry & Materials technology area. All 3 pending office actions are concentrated in 1 distinct art unit, which suggests a specialized technological focus for the current portfolio. This concentration allows for a consistent examination environment despite the involvement of 3 distinct examiners. The use of 1 distinct art unit allows for the application of consistent legal standards across the company's filings.
SEYED BEHROOZ GHORISHI serves as the busiest examiner for the company, with 1 pending office action under review. Because there are 3 distinct examiners for the 3 pending office actions, each examiner is managing an individual matter. The presence of only 1 distinct art unit for all 3 pending office actions may lead to more predictable prosecution outcomes due to the shared institutional knowledge within that specific unit. This structure indicates that while different individuals are reviewing the applications, they are all operating within the same departmental framework.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GHORISHI, SEYED BEHROOZ | 1 | 68.8% | +44.0% |
| CARTER, CHRISTOPHER W | 1 | 74.8% | +20.3% |
| SIDDIQUEE, TAMEEM | 1 | 61.9% | +37.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19043772 | INJECTION MOLDING METHOD AND INJECTION MOLDING MACHINE | GHORISHI, SEYED BEHROOZ | — |
| 18901149 | PREVIEW DISPLAY FUNCTION FOR OPERATION OF INJECTION MOLDING MACHINE | CARTER, CHRISTOPHER W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19043772 | INJECTION MOLDING METHOD AND INJECTION MOLDING MACHINE | GHORISHI, SEYED BEHROOZ | — |
| 18901149 | PREVIEW DISPLAY FUNCTION FOR OPERATION OF INJECTION MOLDING MACHINE | CARTER, CHRISTOPHER W | — |
| 18838434 | OPERATION MANAGEMENT SYSTEM AND OPERATION MANAGEMENT METHOD FOR INJECTION MOLDING MACHINE | SIDDIQUEE, TAMEEM | — |
| Art Unit | Apps |
|---|---|
| 1748 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19043772 | INJECTION MOLDING METHOD AND INJECTION MOLDING MACHINE | GHORISHI, SEYED BEHROOZ | 1748 | §102§103§112 | Non-Final OA | — | Pending | Feb 03, 2025 |
| 18901149 | PREVIEW DISPLAY FUNCTION FOR OPERATION OF INJECTION MOLDING MACHINE | CARTER, CHRISTOPHER W | — | §101§102§103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18838434 | OPERATION MANAGEMENT SYSTEM AND OPERATION MANAGEMENT METHOD FOR INJECTION MOLDING MACHINE | SIDDIQUEE, TAMEEM | — | §103 | Non-Final OA | — | Pending | Aug 14, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial